Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CAIthis companyCaris Life Sciences, Inc.	$25.12	-14.13×	13.19×	9.38×	632.55×	-380.9%	66.4%	5.6%	-66.2%	-93.2%	4.5%	0.9%	0.66×	-36.8×	0.79×	7.85×	0.0%	5	7.69	2	C+
ADPTAdaptive Biotechnologies Corporation	$30.29	-41.64×	11.26×	8.9×	-89.6×	-203.3%	74.2%	-20.6%	-21.5%	-27.2%	-13.1%	-2.0%	1.28×	-7.04×	-4.85×	3.34×	0.0%	4	2.73	1	D+
BIAFbioAffinity Technologies, Inc.	$2.65	-0.14×	0.28×	0.33×	0.23×	-141990.8%	23.2%	-171.6%	-242.0%	-204.9%	-125.3%	-462.3%	0.16×	0.37×	-238.27×	2.6×	0.0%	3	-16.55	2	C
CSTLCastle Biosciences, Inc.	$33.23	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
IMDXInsight Molecular Diagnostics Inc.	$2.69	-4.55×	-7.26×	56.37×	-4.6×	-189.3%	4.7%	-754.1%	-1238.5%	159.6%	-197.4%	-11.1%	-0.11×	0.17×	-280.53×	1.27×	0.0%	1	-23.74	2	C
NEONeoGenomics, Inc.	$17.33	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
Peer median	—	-14×	1.8×	3.28×	-4.6×	-203.3%	38.8%	-20.6%	-21.5%	-12.9%	-13.1%	-2.0%	0.16×	-7.04×	-238.27×	3.34×	0.0%	3	2.5	2	—